Scandinavian ChemoTech signs commissioned research agreement with Kalqyl
Scandinavian ChemoTech AB has entered into an agreement with Kalqyl AB to carry out an initial analysis of the Company.The purpose of the analysis is to increase the stock market's knowledge of ChemoTech and to make the Company's value-driving factors visible in the short and the long term.
After publication, the analysis will be disseminated on Kalqyl's Twitter channels and also via Nordnet, Avanza, Di.se, Eikon, Bloomberg and more.
The analysis is expected to be published in July 2022.
About Kalqyl
Kalqyl is run by analysts Oliver Hamrin, Peter Westberg and